Domain
Pharmacy
NDC codes, dispensing, PBM, RxNorm and formulary management
1,993 pharmacy terms
Identifies the pharmacist, clinician, or formulary committee member who authorized a drug formulation for use or formulary inclusion. Captured in pharmacy and clinical systems to maintain an auditable approval chain, supporting regulatory compliance and accountability for formulary management decisions.
Records the exact time a compounded or specialty drug formulation arrived at the dispensing pharmacy or clinical site. Used in pharmacy operations and cold-chain logistics tracking to verify delivery windows, maintain temperature-sensitive medication integrity, and support chain-of-custody documentation.
The calendar date on which a drug formulation was received at the dispensing pharmacy or clinical facility. Used in pharmacy inventory management and specialty drug distribution to verify timely delivery, initiate quality checks, and trigger dispensing workflows for time-sensitive medications.
A structured clinical or pharmacist evaluation of a drug formulation's suitability for a specific patient or indication, documenting therapeutic appropriateness, stability, and safety considerations. Used in medication management and prior authorization workflows to support formulary exception decisions and clinical interventions.
Represents the outstanding financial amount remaining for a specific drug preparation type after payments or adjustments have been applied. Used in pharmacy billing, PBM reconciliation, and claims processing systems to track unpaid drug costs, manage accounts receivable, and support financial reporting across adjudication cycles.
The total dollar amount submitted by a pharmacy or healthcare facility to a payer for a dispensed drug formulation before adjudication adjustments. Represents the gross charge on a pharmacy claim and serves as the starting value from which allowed amounts, copays, and other cost-sharing calculations are derived.
Records the date on which a specific drug formulation record was first introduced or approved within a healthcare data system. Used in pharmacy and PBM databases to track the lifecycle of drug preparation types, support formulary management, and maintain historical audit trails for regulatory and compliance reporting.
The arterial pressure value for a drug preparation type. Used in healthcare data management and clinical workflows. This field is commonly used in electronic health records (EHR), healthcare information systems (HIS), and clinical data warehouses for formulation management and reporting.
The calendar date on which a drug formulation order, prescription, or formulary listing was formally cancelled. Used in pharmacy systems to terminate active dispensing workflows, update inventory records, and generate audit trails for regulatory reporting and medication safety reviews.
Classifies a drug preparation type into a defined grouping such as oral, injectable, topical, or compounded within pharmacy and PBM systems. Used in formulary management, drug utilization review, and clinical decision support tools to apply tier-based benefit rules, prior authorization logic, and therapeutic substitution workflows.
The price charged by a pharmacy or compounding facility for preparing and dispensing a specific drug formulation, before payer adjustments or patient cost-sharing. Captured on pharmacy claims and billing records, this amount forms the basis for reimbursement calculations and pharmacy revenue reporting.
The primary clinical indication or therapeutic reason documented to justify prescribing or compounding a specific drug formulation. Captured during medication reviews or prior authorization requests to establish medical necessity and ensure the formulation is appropriate for the patient's presenting condition.
Identifies a subordinate drug preparation type linked to a parent formulation record in a hierarchical pharmacy data model. Used in PBM and EHR drug master files to represent relationships between branded and generic variants, concentration levels, or delivery mechanisms, supporting formulary equivalence and drug substitution logic.
The municipality associated with the compounding pharmacy, dispensing facility, or manufacturer producing a specific drug formulation. Used in pharmacy licensing, regulatory compliance reporting, and supply chain management to identify geographic sourcing and ensure dispensing entities meet applicable state licensing requirements.
Designates the classification tier assigned to a drug preparation type within a structured pharmaceutical taxonomy, such as therapeutic class or chemical class. Used in PBM formulary systems, EHR clinical decision support, and drug utilization management to apply benefit rules, coverage policies, and step therapy protocols.
Stores the standardized alphanumeric identifier assigned to a specific drug preparation type within pharmacy, PBM, or EHR systems. Commonly aligned with NDC, RxNorm, or internal formulary coding schemes, this field drives claims adjudication, drug lookup, formulary tier assignment, and drug utilization review processes across healthcare data platforms.
The portion of a drug formulation's cost that a member is responsible for paying as a percentage of the allowed amount after any deductible is met, as defined by their pharmacy benefit plan. Captured during claims adjudication to calculate member out-of-pocket liability and determine the payer's reimbursement share.
Contains free-text notations entered by pharmacists, data stewards, or clinical staff regarding a specific drug preparation type in pharmacy or PBM systems. Used to document special handling instructions, compounding notes, formulary exceptions, or data quality flags that supplement structured fields in drug master and claims processing records.
The date on which compounding, preparation, or manufacturing of a specific drug formulation was finalized and deemed ready for dispensing or delivery. Used in pharmacy operations to track production timelines, calculate stability windows, assign expiration dates, and meet regulatory documentation requirements for compounded medications.
A flag designating that a drug formulation record contains sensitive information requiring restricted access, such as formulations associated with behavioral health, reproductive health, or substance use treatment. Controls data visibility within pharmacy and clinical systems to comply with applicable privacy regulations including 42 CFR Part 2.